Literature DB >> 23236061

Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity.

Yuichi Yagita1, Nozomi Kuse, Kimiko Kuroki, Hiroyuki Gatanaga, Jonathan M Carlson, Takayuki Chikata, Zabrina L Brumme, Hayato Murakoshi, Tomohiro Akahoshi, Nico Pfeifer, Simon Mallal, Mina John, Toyoyuki Ose, Haruki Matsubara, Ryo Kanda, Yuko Fukunaga, Kazutaka Honda, Yuka Kawashima, Yasuo Ariumi, Shinichi Oka, Katsumi Maenaka, Masafumi Takiguchi.   

Abstract

Pol283-8-specific, HLA-B*51:01-restricted, cytotoxic T cells (CTLs) play a critical role in the long-term control of HIV-1 infection. However, these CTLs select for the reverse transcriptase (RT) I135X escape mutation, which may be accumulating in circulating HIV-1 sequences. We investigated the selection of the I135X mutation by CTLs specific for the same epitope but restricted by HLA-B*52:01. We found that Pol283-8-specific, HLA-B*52:01-restricted CTLs were elicited predominantly in chronically HIV-1-infected individuals. These CTLs had a strong ability to suppress the replication of wild-type HIV-1, though this ability was weaker than that of HLA-B*51:01-restricted CTLs. The crystal structure of the HLA-B*52:01-Pol283-8 peptide complex provided clear evidence that HLA-B*52:01 presents the peptide similarly to HLA-B*51:01, ensuring the cross-presentation of this epitope by both alleles. Population level analyses revealed a strong association of HLA-B*51:01 with the I135T mutant and a relatively weaker association of HLA-B*52:01 with several I135X mutants in both Japanese and predominantly Caucasian cohorts. An in vitro viral suppression assay revealed that the HLA-B*52:01-restricted CTLs failed to suppress the replication of the I135X mutant viruses, indicating the selection of these mutants by the CTLs. These results suggest that the different pattern of I135X mutant selection may have resulted from the difference between these two CTLs in the ability to suppress HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23236061      PMCID: PMC3571484          DOI: 10.1128/JVI.02572-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Nonstandard peptide binding revealed by crystal structures of HLA-B*5101 complexed with HIV immunodominant epitopes.

Authors:  K Maenaka; T Maenaka; H Tomiyama; M Takiguchi; D I Stuart; E Y Jones
Journal:  J Immunol       Date:  2000-09-15       Impact factor: 5.422

2.  Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus.

Authors:  P Borrow; H Lewicki; X Wei; M S Horwitz; N Peffer; H Meyers; J A Nelson; J E Gairin; B H Hahn; M B Oldstone; G M Shaw
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

3.  Multilayered defense in HLA-B51-associated HIV viral control.

Authors:  YongHong Zhang; YanChun Peng; HuiPing Yan; Keyi Xu; Masumichi Saito; Hao Wu; XinYue Chen; Srinika Ranasinghe; Nozomi Kuse; Tim Powell; Yan Zhao; WeiHua Li; Xin Zhang; Xia Feng; Ning Li; Aleksandra Leligdowicz; XiaoNing Xu; Mina John; Masafumi Takiguchi; Andrew McMichael; Sarah Rowland-Jones; Tao Dong
Journal:  J Immunol       Date:  2011-06-13       Impact factor: 5.422

Review 4.  Immunologic control of HIV-1.

Authors:  Rajesh T Gandhi; Bruce D Walker
Journal:  Annu Rev Med       Date:  2002       Impact factor: 13.739

5.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection.

Authors:  P Borrow; H Lewicki; B H Hahn; G M Shaw; M B Oldstone
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

8.  HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognition.

Authors:  Toshiyuki Miura; Mark A Brockman; Arne Schneidewind; Michael Lobritz; Florencia Pereyra; Almas Rathod; Brian L Block; Zabrina L Brumme; Chanson J Brumme; Brett Baker; Alissa C Rothchild; Bin Li; Alicja Trocha; Emily Cutrell; Nicole Frahm; Christian Brander; Ildiko Toth; Eric J Arts; Todd M Allen; Bruce D Walker
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

9.  Progression to AIDS in South Africa is associated with both reverting and compensatory viral mutations.

Authors:  Kuan-Hsiang Gary Huang; Dominique Goedhals; Jonathan M Carlson; Mark A Brockman; Swati Mishra; Zabrina L Brumme; Stephen Hickling; Christopher S W Tang; Toshiyuki Miura; Chris Seebregts; David Heckerman; Thumbi Ndung'u; Bruce Walker; Paul Klenerman; Dewald Steyn; Philip Goulder; Rodney Phillips; Cloete van Vuuren; John Frater
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

10.  Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA.

Authors:  Alasdair Leslie; Daniel Kavanagh; Isobella Honeyborne; Katja Pfafferott; Charles Edwards; Tilly Pillay; Louise Hilton; Christina Thobakgale; Danni Ramduth; Rika Draenert; Sylvie Le Gall; Graz Luzzi; Anne Edwards; Christian Brander; Andrew K Sewell; Sarah Moore; James Mullins; Corey Moore; Simon Mallal; Nina Bhardwaj; Karina Yusim; Rodney Phillips; Paul Klenerman; Bette Korber; Photini Kiepiela; Bruce Walker; Philip Goulder
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

View more
  16 in total

1.  Population-Level Immune-Mediated Adaptation in HIV-1 Polymerase during the North American Epidemic.

Authors:  Natalie N Kinloch; Daniel R MacMillan; Anh Q Le; Laura A Cotton; David R Bangsberg; Susan Buchbinder; Mary Carrington; Jonathan Fuchs; P Richard Harrigan; Beryl Koblin; Margot Kushel; Martin Markowitz; Kenneth Mayer; M J Milloy; Martin T Schechter; Theresa Wagner; Bruce D Walker; Jonathan M Carlson; Art F Y Poon; Zabrina L Brumme
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

2.  Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.

Authors:  Ming-Han Chloe Tsai; Supriya Singh; Emily Adland; Philip Goulder
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.

Authors:  Hayato Murakoshi; Tomohiro Akahoshi; Madoka Koyanagi; Takayuki Chikata; Takuya Naruto; Rie Maruyama; Yoshiko Tamura; Naoki Ishizuka; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity.

Authors:  Natalie N Kinloch; Guinevere Q Lee; Jonathan M Carlson; Steven W Jin; Chanson J Brumme; Helen Byakwaga; Conrad Muzoora; Mwebesa B Bwana; Kyle D Cobarrubias; Peter W Hunt; Jeff N Martin; Mary Carrington; David R Bangsberg; P Richard Harrigan; Mark A Brockman; Zabrina L Brumme
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

Review 5.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

6.  Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.

Authors:  Hayato Murakoshi; Madoka Koyanagi; Takayuki Chikata; Mohammad Arif Rahman; Nozomi Kuse; Keiko Sakai; Hiroyuki Gatanaga; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

7.  Global Database-Driven Assessment of HIV-1 Adaptation to the Immune Repertoires of Human Populations.

Authors:  Aram Karakas; Zabrina L Brumme; Art F Y Poon
Journal:  J Virol       Date:  2015-08-05       Impact factor: 5.103

8.  Broad Recognition of Circulating HIV-1 by HIV-1-Specific Cytotoxic T-Lymphocytes with Strong Ability to Suppress HIV-1 Replication.

Authors:  Hayato Murakoshi; Nozomi Kuse; Tomohiro Akahoshi; Yu Zhang; Takayuki Chikata; Mohamed Ali Borghan; Hiroyuki Gatanaga; Shinichi Oka; Keiko Sakai; Masafumi Takiguchi
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

Review 9.  Human Leukocyte Antigen Diversity: A Southern African Perspective.

Authors:  Mqondisi Tshabalala; Juanita Mellet; Michael S Pepper
Journal:  J Immunol Res       Date:  2015-08-12       Impact factor: 4.818

10.  Modulation of host immune defenses by Aeromonas and Yersinia species: convergence on toxins secreted by various secretion systems.

Authors:  Jason A Rosenzweig; Ashok K Chopra
Journal:  Front Cell Infect Microbiol       Date:  2013-10-30       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.